Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dead site. Hotcopper is where it's at.
Roth Capital just initiated coverage as a buy at .13.
https://t.co/FaKmt7Kqyh?amp=1
Lots of clues in this interview yesterday with Leslie Chong of Imugene.
Volume up today at almost 600K and the ASX has been huge for several days. General consensus is big news pending and Laurence Fishburn documentary to be launched about Imugene on Monday.
I believe but have no hard knowledge that price sensitive news will possibly be released to coincide with the documentary and it's been due for sometime on Her-Vaxx phase 2 clinical trials.
Videos, news letters etc from Imugene indicate some good potential releases. Good luck to all who invest in Imugene. Most importantly, a great new way to treat cancer afflicted.
Imugene is up another 20% on the ASX last night. The ads are on US TV now on MSNBC, CNN, Discovery and others. The Laurence Fishburn documentary on Imugene airs Monday and several time throughout the next 12 months on I think PBS.
I expect more very positive announcements over the next coming weeks. I believe the time has come we will see more positive news on Her-Vaxx and others.
Also, with positive results will come the interest of big pharma if not already there and some potential licensing deals and maybe buyout. All in my opinion but seems poised in this direction based in recents news, videos by LC and other info.
Up 21.48% today on great news coming out. Documentary on prime time with Laurence Fishburn, new trials beginning, seemingly great data on phase 2 of Her-Vaxx pending and more.
Imugene commercials now on prime time leading up to Lawrence Fishburn documentary on the company.
Watch it soar investors. Better get in board while you can.
https://twitter.com/TeamImugene/status/1284978851303522313?s=19
Announcements are rolling out. Now PD-1 Vaxx is starting phase 1. IUGNF is exciting.
Very exciting things Imugene is doing. I expect some news out soon on phase 2 of HerVaxx. Hope all is as good as I think it will be.
Yes, I hold a significant amount. Phase 2 HerVaxx data due anytime. I am unsure of USA listing and suspect big pharma will swoop in and buy them up before that if it was planned. USA listing would definitely bring much more on share price.
Reverse split would be cool in my book. They have a lot of IP and a great board. Imugene will go high with positive HerVaxx news and new clinical trials for CF33 etc.
Go to hotcopper.com under imugene and read there. A lot of good info and some bad too.
That post was good. I read Hot Copper daily. Right now huge volume on ASX and price keeps creeping up.
I hold a significant amount of IUGNF and believe it will continue up. With new clinical trials starting and HerVaxx phase 2 data out soon I believe we will see very strong share price increases.
It's up 15% now on ASX on news yesterday from phase 2 clinical trials. I'm in TX from AZ and in long. Their IP is good, world class leadership and it will in my opinion make a lot of investors very happy.
https://t.co/IXotYN9MaE?amp=1
Good info. I am accumulating at these low prices. I think good news coming on HerVaxx too.
Sorry site reposted with error.
I hold a nice piece as I've stated before and am seeing some good legit stuff coming out. Phase 2 on Her-Vaxx due any time. Lots in the pipeline and big pharma have been making aquisitions so article below is good.
It's cheap now but I suspect in next 3 months it will be much more.
https://www.thepharmaletter.com/article/eligible-imugene-thinking-ahead-to-actively-developing-a-bd-department
I hold a nice piece as I've stated before and am seeing some good legit stuff coming out. Phase 2 on Her-Vaxx due any time. Lots in the pipeline and big pharma have been making aquisitions so article below is good.
It's cheap now but I suspect in next 3 months it will be much more.
https://www.thepharmaletter.com/article/eligible-imugene-thinking-ahead-to-actively-developing-a-bd-department
Been away for a while moving. I have a significant holding in IUGNF and today they just got US patent for Her-Vaxx. I think interim phase 2 is looming and patent protects it. I suspect they may be large Pharma buyers looking.
It's up over 13% on ASX TONIGHT SO I think tomorrow in USA should be good movement up. I believe in them and feel it will pay off soon.
Not sure why this stock is not on any radar but I like it. It's traded in ASX and can be bought under IUGNF. It's up past couple days and trade volumn today was almost 1,000,000.
Normal days are under 100K so it moved a lot today. They have some very good management, good pipeline of tests on various cancer treatments and patents that go into late 2030's.
Does anyone else watch this company? Thoughts?